Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus

Area of Science:

• Immunology
• Pharmacology
• Clinical Medicine

Background:

• Tumor necrosis factor (TNF) inhibitors are widely used for inflammatory diseases.
• While effective, these therapies carry risks of serious adverse events.
• Adverse events include cardiac issues and autoimmune reactions like drug-induced lupus.

Purpose of the Study:

• To highlight serious and unexpected adverse events associated with TNF inhibitor therapy.
• To emphasize the importance of recognizing and managing these rare toxicities.
• To inform clinical practice for the safe utilization of anti-TNF agents.

Main Methods:

• Review of reported adverse events in patients undergoing TNF inhibitor therapy.
• Analysis of the characteristics of serious and unexpected toxicities.
• Assessment of the predictability and avoidability of these events.

Main Results:

• Serious adverse events, including heart failure and drug-induced lupus, have been documented.
• These events are generally recognizable but difficult to predict or prevent.
• Avoidance of the drug is the only certain method to prevent these toxicities.

Conclusions:

• TNF inhibitor therapy offers significant benefits to many patients.
• A thorough understanding of rare toxicities is essential for clinicians.
• Minimizing morbidity requires informed and intelligent use of anti-TNF therapies.